Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Labels

March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info: https://youtu.be/811v7RLXP9M
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country
MEBO TMAU TESTING DISCONTINUED
(2012-2017)

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :
https://forms.gle/vem2TjepKobYZPBu8

current participants : 113 (update 18dec20)

Saturday, December 5, 2009

Woman awarded $3 million damages for unfair dismissal including a body odor problem

A lady in California was awarded $20 million from her former employer for a number of reasons, including having panic attacks which she said the medication for it caused her to have an "embarrassing body odor". The court of appeal reduced the amount to $3 million. The body odor was only 1 aspect of the 'evidence' against her employer and supervisor, who she said made disparaging remarks despite "knowing" it was a "result of the medication". It doesn't seem to say what the odor smelt of. Possibly this is a precedent that body odor as a medical condition could have some employment law rights.

Short article on the Charlene Roby body odor dismissal case

Roby versus McKesson body odor case : full legal paper in pdf

...The Court of Appeal suggested that supervisor Schoener‟s demeaning
comments about Roby‟s body odor were necessary personnel management actions,
not acts of harassment, because Schoener needed to take action in response to the
complaints of other employees. (See Hannoon v. Fawn Eng’g Corp. (8th Cir.
2003) 324 F.3d 1041, 1047 [Title VII case].) Here, however, the evidence
supports the jury‟s conclusion that Schoener handled the matter in a way that was
unnecessarily demeaning, including reprimanding Roby in front of coworkers and
telling Roby “to take more showers.” It was the demeaning manner in which
Schoener addressed this issue that constituted the harassment...

0 comments:

Post a Comment